# Compliance with 21 CFR Part 1271150(c)(1) – Manufacturing Arrangements:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/compliance-with-21-cfr-part-1271150c1-manufacturing-arrangements-guidance-for-industry/21f3b771-082c-4fa4-bcb3-11816cc92176

> FDA guidance document: Compliance with 21 CFR Part 1271150(c)(1) – Manufacturing Arrangements:  Guidance for Industry. Issue date: September 08, 2006. Get complete insights and analysis.

---

## Details

- Title: Compliance with 21 CFR Part 1271150(c)(1) – Manufacturing Arrangements:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2006-09-08
- Last Changed: 2019-05-17

## Related Documents

- [Availability of FDA’s eSubmitter Program for Regulatory Submissions from Licensed Blood Establishments:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/availability-of-fdas-esubmitter-program-for-regulatory-submissions-from-licensed-blood-establishments-guidance-for-industry/63bf2e4e-93ca-4693-8f9c-036c97157aea)
- [FDA Review of Vaccine Labeling Requirements for Warnings, Use Instructions, and Precautionary Information:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/fda-review-of-vaccine-labeling-requirements-for-warnings-use-instructions-and-precautionary-information-guidance-for-industry/99ec601e-f337-4c0d-8e45-f7e53d6623c3)
- [Certain Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Recovered from Donors Who Were Tested for Communicable Diseases Using Pooled Specimens or Diagnostic Tests:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/certain-human-cells-tissues-and-cellular-and-tissue-based-products-hctps-recovered-from-donors-who-were-tested-for-communicable-diseases-using-pooled-specimens-or-diagnostic-tests-guidance-for-industry/2badf630-8585-45e0-8caf-a8078914403e)